Skip to main content
SpringerLink
Log in
Book cover

Foundations of Corneal Disease pp 307–330Cite as

Epidemiology of Corneal Diseases

  • Chapter
  • First Online:

Abstract

Epidemiology is the study of the distribution and determinants of disease and the application of this understanding to the treatment and prevention of health conditions [1]. In essence, epidemiology tells us about the “who,” “when,” “where,” and “how” of human disease. Although the spectrum of corneal disease is wide, there are many conditions that have yet to be studied in depth from an epidemiologic perspective. In this chapter we focus our efforts on diseases – including dry eye, trachoma, and microbial corneal ulceration – where epidemiology has played a significant role in furthering our understanding of the disease burden in populations, risk factors for disease occurrence or progression, natural history, and most importantly, opportunities for prevention.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Epidemiology. World Health Organization. WHO 2018. http://www.who.int/topics/epidemiology/en/. Accessed 2 Oct 2018.

  2. Johnson GJ, Minassian DC, Weale RA, West SK. The epidemiology of eye disease. 2012 No.Ed.3: 455–486.

    Google Scholar 

  3. Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry. 2010;19(3):227–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Schein OD, Muñoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124(6):723–8.

    Article  CAS  PubMed  Google Scholar 

  5. Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74(8):624–31.

    Article  CAS  PubMed  Google Scholar 

  6. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105(6):1114–9.

    Article  CAS  PubMed  Google Scholar 

  7. Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2003;31(3):229–32.

    Article  PubMed  Google Scholar 

  8. Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157(4):799–806.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, Tan DT. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86(12):1347–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110(6):1096–101.

    Article  PubMed  Google Scholar 

  11. Shimmura S, Shimazaki J, Tsubota K. Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea. 1999;18(4):408–11.

    Article  CAS  PubMed  Google Scholar 

  12. Uchino M, Dogru M, Uchino Y, et al. Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol. 2008;146(6):925–9.e2.

    Article  PubMed  Google Scholar 

  13. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, Viso E, Vitale S, Jones L. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–65.

    Article  PubMed  Google Scholar 

  14. Sullivan DA, Rocha EM, Aragona P, Clayton JA, Ding J, Golebiowski B, Hampel U, McDermott AM, Schaumberg DA, Srinivasan S, Versura P, Willcox MDP. TFOS DEWS II sex, gender, and hormones report. Ocul Surf. 2017;15(3):284–333.

    Article  PubMed  Google Scholar 

  15. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–26.

    Article  PubMed  Google Scholar 

  16. Schaumberg DA, Dana MR, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127:763–8.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799–806.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008;85(8):668.e74.

    Article  Google Scholar 

  19. Vehof J, Kozareva D, Hysi PG, Hammond CJ. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol. 2014;98(12):1712e7.

    Article  Google Scholar 

  20. Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157(4):799e806. (2.01x)

    Article  PubMed  PubMed Central  Google Scholar 

  21. Uchino M, Nishiwaki Y, Michikawa T, Shirakawa K, Kuwahara E, Yamada M, et al. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology. 2011;118(12):2361e7. (4.36x)

    Article  PubMed  Google Scholar 

  22. Uchino M, Dogru M, Uchino Y, Fukagawa K, Shimmura S, Takebayashi T, et al. Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol. 2008;146(6):925e9. e2.

    Article  Google Scholar 

  23. Ang RT, Dartt DA, Tsubota K. Dry eye after refractive surgery. Curr Opin Ophthalmol. 2001;12:318–22.

    Article  CAS  PubMed  Google Scholar 

  24. Albietz JM, Lenton LM, McLennan SG. Chronic dry eye and regression after laser in situ keratomileusis for myopia. J Cataract Refract Surg. 2004;30(3):675–84.

    Article  PubMed  Google Scholar 

  25. Hammond MD, Madigan WP Jr, Bower KS. Refractive surgery in the United States Army, 2000–2003. Ophthalmology. 2005;112:184–90.

    Article  PubMed  Google Scholar 

  26. Hovanesian JA, Shah SS, Maloney RK. Symptoms of dry eye and recurrent erosion after refractive surgery. J Cataract Refract Surg. 2001;27:577–84.

    Article  CAS  PubMed  Google Scholar 

  27. Battat L, Macri A, Dursen D, et al. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology. 2001;108:1230–5.

    Article  CAS  PubMed  Google Scholar 

  28. Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008;85(8):668e74.

    Article  Google Scholar 

  29. Schein OD, Hochberg MC, Muñoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999;159(12):1359–63.

    Article  CAS  PubMed  Google Scholar 

  30. Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol. 2004;122(3):369–73.

    Article  PubMed  Google Scholar 

  31. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;286(17):2114–9.

    Article  CAS  PubMed  Google Scholar 

  32. Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol. 2008;8:10.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lemp MA. Dry eye (Keratoconjunctivitis Sicca), rheumatoid arthritis, and Sjögren’s syndrome. Am J Ophthalmol. 2005;140(5):898–9.

    Article  PubMed  Google Scholar 

  34. Schein OD, Hochberg MC, Muñoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999;159(12):1359–63.

    Article  CAS  PubMed  Google Scholar 

  35. Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol. 2009;93(5):563–8.

    Article  CAS  PubMed  Google Scholar 

  36. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Munoz B, Stare D, Mkocha H, et al. Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci. 2011;52(12):8806–10.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Taylor HR. Trachoma: a blinding scourge from the Bronze Age to the twenty first century. Centre for Eye Research Australia: Melbourne; 2008.

    Google Scholar 

  39. Taylor HR, Burton MJ, Haddad D, West S, Wright H. Trachoma. Lancet. 2014;384(9960):2142–52.

    Article  PubMed  Google Scholar 

  40. Trachoma. World Health Organization. 2018. http://www.who.int/trachoma/en/. Accessed 15 Aug 2018.

  41. International Coalition for Trachoma Control. The end in sight—2020 INSight. International Coalition for Trachoma Control. 2011. https://www.cbm.org/article/downloads/75741/2020_INSight__English_.pdf. Accessed 19 Sept 2018.

  42. Bartlett S, Haslam D, Bush S, Haddad D. Elimination through collaboration: success factors in a global consortium. Int Health. 2019;11(1):24–9. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  43. Solomon AW, Kurylo E. The Global Trachoma Mapping Project. Community Eye Health. 2014;27(85):18.

    PubMed  PubMed Central  Google Scholar 

  44. Solomon AW, Pavluck AL, Courtright P, et al. The Global Trachoma Mapping Project: methodology of a 34-country population-based study. Ophthalmic Epidemiol. 2015;22(3):214–25.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Trotignon G, Jones E, Engels T, et al. The cost of mapping trachoma: Data from the Global Trachoma Mapping Project. PLoS Negl Trop Dis. 2017;11(10):e0006023.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Strachan CE. End of Project Evaluation: Evaluation Report. Sightsavers International. 31 March 2016.

    Google Scholar 

  47. Cogan JE. Trachoma. World Health Organization. 18 October 2018. http://www.who.int/news-room/fact-sheets/detail/trachoma. Accessed 20 Oct 2018.

  48. Bero B, Macleod C, Alemayehu W, et al. Prevalence of and risk factors for trachoma in Oromia Regional State of Ethiopia: results of 79 population-based prevalence surveys conducted with the Global Trachoma Mapping Project. Ophthalmic Epidemiol. 2016;23(6):392–405.

    Article  PubMed  Google Scholar 

  49. Sherief ST, Macleod C, Gigar G. The prevalence of trachoma in Tigray Region, Northern Ethiopia: results of 11 population-based prevalence surveys completed as part of the Global Trachoma Mapping Project. Ophthalmic Epidemiol. 2016;23.(Suppl 1:94–9.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Adera TH, Macleod C, Endriyas M, et al. Prevalence of and risk factors for trachoma in Southern Nations, Nationalities, and Peoples’ Region, Ethiopia: results of 40 Population-Based Prevalence Surveys Carried Out with the Global Trachoma Mapping Project. Ophthalmic Epidemiol. 2016;23(Suppl 1):84–93.

    Article  PubMed  PubMed Central  Google Scholar 

  51. https://www.taskforce.org/case-study/global-trachoma-mapping-project-determining-prevalence-help-eliminate-trachoma-2020.

  52. Fine D, West S. Absence of a relationship between malnutrition and trachoma in preschool children. Ophthalmic Epidemiol. 1997;4:83–8.

    Article  CAS  PubMed  Google Scholar 

  53. Smith AG, Broman AT, Alemayehu W, et al. Relationship between trachoma and chronic and acute malnutrition in children in rural Ethiopia. J Trop Pediatr. 2007;53(5):308–12.

    Article  PubMed  Google Scholar 

  54. West SK, Congdon N, Katala S, Mele L. Facial cleanliness and risk of trachoma in families. Arch Ophthalmol. 1991;109(6):855–7.

    Article  CAS  PubMed  Google Scholar 

  55. West S, Muñoz B, Lynch M, et al. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet. 1995;345:155–8.

    Article  CAS  PubMed  Google Scholar 

  56. Taylor HR, Rapoza PA, West S, et al. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci. 1989;30:1823–33.

    CAS  PubMed  Google Scholar 

  57. Polack S, Kuper H, Solomon AW, et al. The relationship between prevalence of active trachoma, water availability and its use in a Tanzanian village. Trans R Soc Trop Med Hyg. 2006;100(11):1075–83.

    Article  PubMed  Google Scholar 

  58. Abdou A, Munoz BE, Nassirou B, et al. How much is not enough? A community randomized trial of a Water and Health Education programme for Trachoma and Ocular C trachomatis infection in Niger. Trop Med Int Health. 2010;15:98–104.

    Article  PubMed  PubMed Central  Google Scholar 

  59. McCauley AP, Lynch M, Pounds MB, West S. Changing water-use patterns in a water-poor area: lessons for a trachoma intervention project. Soc Sci Med. 1990;31(11):1233–8.

    Article  CAS  PubMed  Google Scholar 

  60. Emerson PM, Bailey RL, Mahdi OS, et al. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma. Trans R Soc Trop Med Hyg. 2000;94:28–32.

    Article  CAS  PubMed  Google Scholar 

  61. Emerson PM, Lindsay SW, Alexander N, et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet. 2004;363:1093–8.

    Article  PubMed  Google Scholar 

  62. West SK, Muñoz B, Turner VM, Mmbaga BBO, Taylor HR. The epidemiology of trachoma in central Tanzania. Int J Epidemiol. 1991;20:1088–92.

    Article  CAS  PubMed  Google Scholar 

  63. Courtright P, Sheppard J, Lane S, et al. Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol. 1991;75:322–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. WHO. Report of the 3rd global scientific meeting on trachoma elimination (Johns Hopkins University, Baltimore, Maryland; 19–20 July, 2010). http://www.who.int/blindness/publications/WORLDHEALTHORGANIZATIONGSMmtgreportFINALVERSION.pdf. Accessed 31 Aug 2018.

  65. Lavett DK, Lansingh VC, Carter MJ, et al. Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions. ScientificWorldJournal. 2013;2013:648106.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Reacher M, Huber M, Canagaratnam R, Alghassany A. A trial of surgery for trichiasis of the upper lid from trachoma. Br J Ophthalmol. 1990;74:109–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Reacher M, Muñoz B, Alghassany A, et al. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol. 1992;110:667–74.

    Article  CAS  PubMed  Google Scholar 

  68. Khandekar R, Mohammed AJ, Courtright P. Recurrence of trichiasis: a long-term follow-up study in the Sultanate of Oman. Ophthalmic Epidemiol. 2001;8:155–61.

    Article  CAS  PubMed  Google Scholar 

  69. Habtamu E, Wondie T, Aweke S, et al. Posterior lamellar versus bilamellar tarsal rotation surgery for trachomatous trichiasis in Ethiopia: a randomised controlled trial. Lancet Glob Health. 2016;4(3):e175–84.

    Article  PubMed  PubMed Central  Google Scholar 

  70. World Health Organization. Trichiasis Surgery for Trachoma. Geneva: World Health Organization; 2013.

    Google Scholar 

  71. Burton MJ, Kinteh F, Jallow O, et al. A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. Br J Ophthalmol. 2005;89:1282–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. West ES, Mkocha H, Munoz B, et al. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci. 2005;46:447–53.

    Article  PubMed  Google Scholar 

  73. West S, Alemayehu W, Munoz B, et al. Azithromycin prevents recurrence of severe trichiasis following trichiasis surgery: STAR trial. Ophthalmic Epidemiol. 2007;14:273–7.

    Article  PubMed  Google Scholar 

  74. Rabiu MM, Abiose A. Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiol. 2001;8(2–3):181–90.

    Article  CAS  PubMed  Google Scholar 

  75. Bowman RJ, Soma OS, Alexander N, et al. Should trichiasis surgery be offered in the village? A community randomised trial of village vs health centre-based surgery. Trop Med Int Health. 2000;5:528–33.

    Article  CAS  PubMed  Google Scholar 

  76. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354(9179):630–5.

    Article  CAS  PubMed  Google Scholar 

  77. WHO. Report of the 3rd global scientific meeting on trachoma elimination (Johns Hopkins University, Baltimore, Maryland; 19–20 July, 2010). http://www.who.int/blindness/publications/3RDGLOBALSCIENTIFICMEETINGONTRACHOMA.pdf. Accessed 29 Aug 2018.

  78. Frick KD, Lietman TM, Holm SO, et al. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull World Health Organ. 2001;79:201–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. WHO. Global alliance for the elimination of blinding trachoma by 2020—progress report on elimination of trachoma, 2012. Wkly Epidemiol Rec. 2013;88:242–51.

    Google Scholar 

  80. Yohannan J, Munoz B, Mkocha H, et al. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma? PRET Ziada trial results. JAMA Ophthalmol. 2013;131:431–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Kalua K, Chisambi A, Chinyanya D, et al. One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation-follicular of 5.0–9.9%: evidence from Malawi. PLoS Negl Trop Dis. 2018;12(6):e0006543.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Baltussen RM, Sylla M, Frick KD, Mariotti SP. Cost-effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol. 2005;12:91–101.

    Article  PubMed  Google Scholar 

  83. Stocks ME, Ogden S, Haddad D, et al. Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis. PLoS Med. 2014;11(2):e1001605.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Ngondi J, Onsarigo A, Matthews F, et al. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study. Lancet. 2006;368(9535):589–95.

    Article  PubMed  Google Scholar 

  85. International Coalition for Trachoma Control. Nepal eliminates trachoma as a public health problem. 21 May 2018. http://www.trachomacoalition.org/news-blogs/nepal-eliminates-trachoma-public-health-problem. Accessed 10 Sept 2018.

  86. World Health Organization. 85 million people treated for trachoma through expanded access to medicine. http://www.who.int/neglected_diseases/news/85_million_people_treated_for_trachoma/en/. Accessed 10 Sept 2018.

  87. World Health Organization. Trachoma elimination: Iranians triumph against the world’s leading infectious cause of blindness. http://www.emro.who.int/media/news/trachoma-elimination-iranians-triumph-against-the-worlds-leading-infectious-cause-of-blindness.html. Accessed 9 Oct 2018.

  88. World Health Organization. Morocco defeats trachoma. http://www.who.int.ezp.welch.jhmi.edu/neglected_diseases/news/Morocco_defeats_trachoma/en/. Accessed 10 Sept 2018.

  89. World Health Organization. Trachoma. http://www.who.int/news-room/fact-sheets/detail/trachoma. 16 February 2018. Accessed 10 Sept 2018.

  90. International Agency for the Prevention of Blindness. Nepal eliminates trachoma. 24 May 2018. https://www.iapb.org/news/nepal-eliminates-trachoma/. Accessed 10 Sept 2018.

  91. World Health Organization. Nepal: first country in South-East Asia validated for eliminating trachoma. 21 May 2018. http://www.who.int/neglected_diseases/news/Nepal-first-country-in-SEARO-validated-for-eliminating-trachoma/en/. Accessed 10 Sept 2018.

  92. Ostler HB, Okumoto M. The changing pattern of the etiology of central bacterial corneal (hypopyon) ulcer. Trans Pac Coast Oto-Ophthalmol Soc. 1976;57:235–46.

    CAS  Google Scholar 

  93. Johnson GJ, Minassian DC, Weale RA, West SK. The epidemiology of eye disease. 2003 No.Ed.2: 393–402.

    Google Scholar 

  94. Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol. 1993;111:1665–71.

    Article  CAS  PubMed  Google Scholar 

  95. Seal DV, Kirkness CM, Bennett HG, Peterson M, Keratitis Study Group. Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye. 1999;22(2):49–57.

    Article  CAS  PubMed  Google Scholar 

  96. Lam DS, Houang E, Fan DS, Lyon D, Seal D, Wong E. Hong Kong Microbial Keratitis Study Group: incidence and risk factors for microbial keratitis in HongKong: comparison with Europe and North America. Eye. 2002;16:608–18.

    Article  CAS  PubMed  Google Scholar 

  97. Gonzales CA, Srinivasan M, Whitcher JP, Smolin G. Incidence of corneal ulceration in Madurai district, South India. Ophthalmic Epidemiol. 1996;3(3):159–66.

    Article  CAS  PubMed  Google Scholar 

  98. World Health Organization Guidelines for the management of corneal ulcer at primary, secondary, and tertiary care health facilities in the South-East Asia Region. SEA/Ophthal/126. WHO Regional Office for South-East Asia 2004; 1–36.

    Google Scholar 

  99. Getshen K, Srinivasan M, Upadhyay MP, et al. Corneal ulceration in South East Asia. I: a model for the prevention of bacterial ulcers at the village level in rural Bhutan. Br J Ophthalmol. 2006;90(3):276–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Upadhyay MP, Karmacharya PC, Koirala S, et al. The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol. 2001;85(4):388–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Schein OD, Ormerod LD, Barraquer E, Alfonso E, Egan KM, Paton BG, et al. Microbiology of contact lens-related keratitis. Cornea. 1989;8:281–5.

    Article  CAS  Google Scholar 

  102. Stapleton F, Carnt N. Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis. Eye. 2012;26:185–93.

    Article  CAS  PubMed  Google Scholar 

  103. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27(1):22–7.

    Article  PubMed  Google Scholar 

  104. Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea. 2008;27(1):33–9.

    Article  PubMed  Google Scholar 

  105. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90(1):38–47.

    Article  CAS  PubMed  Google Scholar 

  106. Galentine PG, Cohen EJ, Laibson PR, et al. Corneal ulcers associated with contact lens wear. Arch Ophthalmol. 1984;102(6):891–4.

    Article  CAS  PubMed  Google Scholar 

  107. Jeng BH, Gritz DC, Kumar AB, et al. Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol. 2010;128(8):1022–8.

    Article  PubMed  Google Scholar 

  108. Dunlop AA, Wright ED, Howlader SA, et al. Suppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol. 1994;22(2):105–10.

    Article  CAS  PubMed  Google Scholar 

  109. Hagan M, Wright E, Newman M, et al. Causes of suppurative keratitis in Ghana. Br J Ophthalmol. 1995;79:1024–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Poole TR, Hunter DL, Maliwa EM, Ramsay AR. Aetiology of microbial keratitis in northern Tanzania. Br J Ophthalmol. 2002;86(8):941–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol. 1997;81:965–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Basak SK, Basak S, Mohanta A, Bhowmick A. Epidemiological and microbiological diagnosis of suppurative keratitis in Gangetic West Bengal, eastern India. Indian J Ophthalmol. 2005;53(1):17–22.

    Article  PubMed  Google Scholar 

  113. Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14(2):61–9.

    Article  PubMed  Google Scholar 

  114. Poggio EC, Glynn RJ, Schein OD, et al. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med. 1989;321(12):779–83.

    Article  CAS  Google Scholar 

  115. Schein OD, Glynn RJ, Poggio EC, et al. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med. 1989;321(12):773–8.

    Article  CAS  Google Scholar 

  116. Schein OD, McNally JJ, Katz J, et al. The incidence of microbial keratitis among wearers of a 30-day silicone hydrogel extended-wear contact lens. Ophthalmology. 2005;112:2172–9.

    Article  PubMed  Google Scholar 

  117. Dart JKG, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses: a case control study. Ophthalmology. 2008;115:1647–54.

    Article  CAS  PubMed  Google Scholar 

  118. Stapleton F, Keay L, Edwards K, et al. The incidence of contact lens–related microbial keratitis in Australia. Ophthalmology. 2008;115(10):1655–62.

    Article  PubMed  Google Scholar 

  119. Morgan P, Efron N, Brennan NA, et al. Risk factors for the development of corneal infiltrative events associated with contact lens wear. Invest Ophthalmol Vis Sci. 2005;46:3136–43.

    Article  PubMed  Google Scholar 

  120. Stapleton F, Dart JKG, Minassian D. Risk factors with contact lens related suppurative keratitis. CLAO J. 1993;19:204–10.

    CAS  PubMed  Google Scholar 

  121. Dart JKG, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet. 1991;338:650–3.

    Article  CAS  PubMed  Google Scholar 

  122. Lakkis C, Anastasopoulos F, Terry C, Borazjani R. Time course of the development of contact lens case and contact lens contamination. Invest Ophthalmol Vis Sci. 2009;50(13):6352.

    Google Scholar 

  123. Buehler PO, Schein OD, Stamler JF, et al. The increased risk of ulcerative keratitis among disposable soft contact lens users. Arch Ophthalmol. 1992;110(11):1555–8.

    Article  CAS  PubMed  Google Scholar 

  124. Khor WB, Aung T, Saw SM, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295(24):2867–73.

    Article  CAS  PubMed  Google Scholar 

  125. Gaujoux T, Chatel MA, Chaumeil C, et al. Outbreak of contact lens-related Fusarium keratitis in France. Cornea. 2008;27(9):1018–21.

    Article  PubMed  Google Scholar 

  126. Ma SK, So K, Chung PH, et al. A multi-country outbreak of fungal keratitis associated with a brand of contact lens solution: the Hong Kong experience. Int J Infect Dis. 2009;13(4):443–8.

    Article  PubMed  Google Scholar 

  127. Chang DC, Grant GB, O'Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296(8):953–63.

    Article  CAS  PubMed  Google Scholar 

  128. Gower EW, Keay LJ, Oechsler RA, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010;117(12):2263–7.

    Article  PubMed  Google Scholar 

  129. Zhang S, Ahearn DG, Noble-Wang JA, et al. Growth and survival of Fusarium solani-F.oxysporum complex on stressed multipurpose contact lens care solution films on plastic surfaces in situ and in vitro. Cornea. 2006;25(10):1210–6.

    Article  PubMed  Google Scholar 

  130. Tu EY, Joslin CE. Recent outbreaks of atypical contact lens-related keratitis: what have we learned? Am J Ophthalmol. 2010;150(5):602–8.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107(4):331–6.

    Article  CAS  PubMed  Google Scholar 

  132. Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea. 1998;17(1):3–10.

    Article  CAS  PubMed  Google Scholar 

  133. Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol. 2002;86(5):536–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Seal DV, Kirkness CM, Bennett HG, et al. Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye. 1999;22(2):49–57.

    Article  CAS  PubMed  Google Scholar 

  135. Joslin CE, Tu EY, McMahon TT, et al. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol. 2006;142(2):212–7.

    Article  PubMed  Google Scholar 

  136. Joslin CE, Tu EY, Shoff ME, et al. The association of contact lens solution use and acanthamoeba keratitis. Am J Ophthalmol. 2007;144(2):169–80.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Acanthamoeba keratitis multiple states, 2005–2007. MMWR Morb Mortal Wkly Rep. 2007;56(21):532–4.

    Google Scholar 

  138. Joslin CE, Tu EY, Shoff ME, et al. The association of contact lens solution use and acanthamoeba keratitis. Am J Ophthalmol. 2007;144(2):169–80.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Yoder J. Surveillance for Acanthamoeba keratitis after an outbreak associated with use of a contact lens solution. Paper presented at: Microbial Testing for Contact Lens Care Products workshop January 22, 2009 Silver Spring, MD.

    Google Scholar 

  140. Mathers WD, Sutphin JE, Lane JA, Folberg R. Correlation between surface water contamination with amoeba and the onset of symptoms and diagnosis of amoeba-like keratitis. Br J Ophthalmol. 1998;82(10):1143–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Radford CF, Bacon AS, Dart JK, Minassian DC. Risk factors for Acanthamoeba keratitis in contact lens users: a case-control study. BMJ. 1995;310:1567–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Stehr-Green JK, Bailey TM, Brandt FH, et al. Acanthamoeba keratitis in soft contact lens wearers. A case-control study. JAMA. 1987;258:57–60.

    Article  CAS  PubMed  Google Scholar 

  143. Verani JR, Lorick SA, Yoder JS, et al. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis. 2009;15:1236–42.

    Article  PubMed  PubMed Central  Google Scholar 

  144. Cope JR, Collier SA, Schein OD, et al. Acanthamoeba keratitis among rigid gas permeable contact lens wearers, United States, 2005–2011. Ophthalmology. 2016;123(7):1435–41.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Xie L, Zhong W, Shi W, et al. Spectrum of fungal keratitis in North China. Ophthalmology. 2006;113(11):1943–8.

    Article  PubMed  Google Scholar 

  146. Ormerod LD, Hertzmark E, Gomez DS, et al. Epidemiology of microbial keratitis in southern California. A multivariate analysis. Ophthalmology. 1987;94(10):1322–33.

    Article  CAS  PubMed  Google Scholar 

  147. Luchs JI, Cohen EJ, Rapuano CJ, Laibson PR. Ulcerative keratitis in bullous keratopathy. Ophthalmology. 1997;104(5):816–22.

    Article  CAS  PubMed  Google Scholar 

  148. Bialasiewicz AA, Shenoy R, Al-Muniri A, Thakral A. Diseases of the adnexa in the tropics: amnion membrane transplantation for noninfectious trachoma-associated corneal ulcers. Ophthalmologe. 2006;103(11):940–4.

    Article  CAS  PubMed  Google Scholar 

  149. Chidambaram JD, Venkatesh Prajna N, Srikanthi P, et al. Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India. Ophthalmic Epidemiol. 2018;25(4):297–305.

    Article  PubMed  PubMed Central  Google Scholar 

  150. Harshal R, Venugopal A, Rameshkumar G, et al. Fungal keratitis caused by exserohilum, an emerging pathogen. Cornea. 2016;35(5):644–6.

    Article  Google Scholar 

  151. Lee MH, Abell RG, Mitra B, et al. Risk factors, demographics and clinical profile of Acanthamoeba keratitis in Melbourne: an 18-year retrospective study. Br J Ophthalmol. 2018;102(5):687–91.

    Article  PubMed  Google Scholar 

  152. Haq Z, Farooq AV, Huang AJ. Infections after refractive surgery. Curr Opin Ophthalmol. 2016;27(4):367–72.

    Article  PubMed  Google Scholar 

  153. de Rojas V, Llovet F, Martinez M, et al. Infectious keratitis in 18,651 laser surface ablation procedures. J Cataract Refract Surg. 2011;37:1822–31.

    Article  PubMed  Google Scholar 

  154. Jan RL, Tai MC, Weng SF, et al. Risk of corneal ulcer in patients with end-stage renal disease: a retrospective large-scale cohort study. Br J Ophthalmol. 2018;102(7):868–72.

    Article  PubMed  Google Scholar 

  155. Maung N, Thant CC, Srinivasan M, et al. Corneal ulceration in South East Asia. II: a strategy for the prevention of fungal keratitis at the village level in Burma. Br J Ophthalmol. 2006;90(8):968–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  156. Srinivasan M, Upadhyay MP, Priyadarsini B, et al. Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in south India using topical antibiotics. Br J Ophthalmol. 2006;90(12):1472–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  157. Mehta A, Chopra S, Mehta P. Antibiotic inhibition of pectolytic and cellulolytic enzyme activity in two Fusarium species. Mycopathologia. 1993;124:185–8.

    Article  CAS  PubMed  Google Scholar 

  158. Day S, Lalitha P, Haug S, et al. Activity of antibiotics against Fusarium and Aspergillus. Br J Ophthalmol. 2009;93(1):116–9.

    Article  CAS  PubMed  Google Scholar 

  159. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986;101:267–73.

    Article  CAS  PubMed  Google Scholar 

  160. Godefrooij DA, de Wit GA, Uiterwaal CS, et al. Age-specific incidence and prevalence of keratoconus: a Nationwide Registration Study. Am J Ophthalmol. 2017;175:169–72.

    Article  PubMed  Google Scholar 

  161. Millodot M, Shneor E, Albou S, et al. Prevalence and associated factors of keratoconus in Jerusalem: a cross-sectional study. Ophthalmic Epidemiol. 2011;18:91–7.

    Article  PubMed  Google Scholar 

  162. The Australian Corneal Graft Registry. Adelaide, Australia; Report 2018.

    Google Scholar 

  163. Musch DC, Niziol LM, Stein JD, et al. Prevalence of corneal dystrophies in the United States: estimates from claims data. Invest Ophthalmol Vis Sci. 2011;52(9):6959–63.

    Article  PubMed  PubMed Central  Google Scholar 

  164. Global Trachoma Atlas. http://www.trachomaatlas.org/global-trachoma-atlas. Accessed 3 Sept 2018.

Download references

Author information

Authors and Affiliations

  1. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Department of Ophthalmology, Baltimore, MD, USA

    Farhan I. Merali & Oliver D. Schein

Authors
  1. Farhan I. Merali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oliver D. Schein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oliver D. Schein .

Editor information

Editors and Affiliations

  1. Louis Block Professor Chair, Department of Ophthalmology and Visual Science, The University of Chicago Medicine & Biological Sciences, Chicago, IL, USA

    Kathryn Colby

  2. Claes H. Dohlman Professor of Ophthalmology, Harvard Medical School, Cornea & Refractive Surgery, Massachusetts Eye & Ear, Boston, MA, USA

    Reza Dana

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Merali, F.I., Schein, O.D. (2020). Epidemiology of Corneal Diseases. In: Colby, K., Dana, R. (eds) Foundations of Corneal Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-25335-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25335-6_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25334-9

  • Online ISBN: 978-3-030-25335-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation